9 research outputs found
Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression
Patients with Alzheimer's disease (AD) are characterized by an altered sensitivity to cortisol-mediated modulation of circulating
lymphocytes. Longitudinal studies are needed to address the clinical applicability of these abnormalities as prognostic factors. Therefore, we
designed a longitudinal study to address the clinical applicability of physiologic modulation of Natural Killer (NK) cell activity as a
prognostic factor in AD. NK activity was assessed as baseline measurement and in response to modulation by cortisol at 10-6M. To verify
the immunophysiological integrity of the NK cell population, we tested augmentation of NK cytotoxicity by human recombinant interleukin
(IL)-2 (100 IU/ml) as control. The response to modulation by cortisol or by IL-2 was significantly greater in patients with AD. Based on
change in the Mini-Mental State score at entry and at 18 months, patients with AD could be assigned to a “fast progression” (Δ > 2 points) or
to a “slow progression” group (Δ ≤ 2 points). The change in the response of NK cytotoxic activity to cortisol, and the strength of the
association of this parameter with circulating activated T cells in time was greater in patients with Fast Progression vs. Slow Progression AD.
These results suggest that changes in the response of NK cells to negative (e.g., cortisol) or positive modifiers (e.g., IL-2) follow progression
of AD
Neuroendocrine immunity in patients with Alzheimer's disease: toward translational epigenetics
The emerging domain of epigenetics in molecular medicine finds application for a variety of patient populations. Here, we present fundamental
neuroendocrine immune evidence obtained in patients with senile dementia of the Alzheimer's type (sDAT), and discuss the implications of these
data from the viewpoint of translational epigenetics of Alzheimer's disease. We followed 18 subjects with mild sDAT treated with acetylcholinesterase
inhibitors, and 10 control subjects matched for age in a repeated measure design every six months for 18 months. We monitored psychosocial profile
(Mini-Mental State Examination, Functional Assessment Staging, Independence in Activities of Daily Living, Depression, Profile of Moods States)
in parallel to immunophenotypic parameters of T cell subpopulations by flow cytometry. Based on change in the mini-mental state score at entry and
at 18 months, patients with sDAT were assigned to a “fast progression” (delta greater than 2 points) or to a “slow progression” group (delta less than
or equal to 2 points). The change in circulating activated T cells (CD3+Dr+) with time in patients with sDAT was significantly inversely correlated with
the change in time in natural killer (NK) cytotoxic activity to cortisol modulation in these patients, which was greater in patients with fast progression,
compared to slow progression sDAT. These data indicate underlying neuroendocrine immune processes during progression of sDAT. Our observations suggest
that psychoimmune measures such as those we have monitored in this study provide relevant information about the evolving physiological modulation in
patients with sDAT during progression of Alzheimer's disease, and point to new or improved translational epigenetic treatment interventions
Retrospective analysis of the application of CT scan in the emergency department to screen clinically asymptomatic COVID-19 before hospital admission
BACKGROUND: The necessity to identify and isolate COVID-19 patients to avoid intrahospital cross infections is particularly felt as a challenge. Clinically occult SARS-CoV-2 infection among patients admitted to the hospital is always considered a risk during the pandemic. The aim of our study is to describe the application of CT scan to reveal unexpected COVID-19 in patients needing hospital admission. METHOD: In our emergency department, we prospectively enrolled adult patients needing hospital admission, without symptoms suspected of COVID-19, and showing negative reverse transcriptase-polymerase chain reaction (RT-PCR) swab test. CT scan was performed to diagnose clinically occult COVID-19 pneumonia. All the exams were read and discussed retrospectively by two expert radiologists and assigned to one of 4 exclusive diagnoses: typical (typCT), indeterminate (indCT), atypical (atyCT), negative (negCT). The clinical characteristics and final diagnoses were described and compared with the results of CT scans. RESULTS: From May 25 to August 18, 2020, we prospectively enrolled 197 patients. They showed 122 negCT, 52 atyCT, 22 indCT, and 1 typCT. Based on the CT imaging, the prevalence of suspected clinically occult COVID-19 pneumonia was 11.6% (23 patients). None had confirmation of SARS-CoV-2 infection after the hospital stay. Nineteen patients had negative serial RT-PCR while in 4 cases, the infection was excluded by clinical follow-up or appearance of positivity of RT-PCR after months. CONCLUSION: Our descriptive analysis confirms that CT scan cannot be considered a valid tool to screen clinically occult COVID-19, when the asymptomatic patients need hospitalization for other conditions. Application of personnel protections and distancing among patients remains the best strategies to limit the possibility of intrahospital cross-infections
(a) Pattern of progression of AD symptoms in terms of the score for the Mini-Mental State Examination-corrected for educational level and ethnicity at 0 to 18 months
<p><b>Copyright information:</b></p><p>Taken from "Physiologic modulation of natural killer cell activity as an index of Alzheimer's disease progression"</p><p></p><p>Bioinformation 2007;1(9):363-366.</p><p>Published online 21 Mar 2007</p><p>PMCID:PMC1891715.</p><p></p> The data in the figure (mean + SD) show that the score on the MMSE-C dropped
significantly faster in patients with Fast Progression AD (